EHC
Encompass Health Corporation Healthcare - Medical Care Facilities Investor Relations →
Encompass Health Corporation (EHC) closed at $98.03 as of 2026-06-19, trading 15.2% above its 200-week moving average of $85.06. The stock is currently moving closer to the line, down from 19.6% last week. The 14-week RSI sits at 47, indicating neutral momentum.
Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.11 ratio) is neutral — neither side is clearly dominating.
Over the past 2025 weeks of data, EHC has crossed below its 200-week moving average 24 times. On average, these episodes lasted 28 weeks. The average one-year return after crossing below was -0.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $9.7 billion, EHC is a mid-cap stock. The company generates a free cash flow yield of 2.9%. Return on equity stands at 25.2%, indicating strong profitability. The stock trades at 3.9x book value.
Over the past 33.5 years, a hypothetical investment of $100 in EHC would have grown to $594, compared to $3097 for the S&P 500. EHC has returned 5.5% annualized vs 10.8% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 53.4% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: EHC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EHC Crosses Below the Line?
Across 20 historical episodes, buying EHC when it crossed below its 200-week moving average produced an average return of -0.9% after 12 months (median +10.0%), compared to +12.9% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +14.0% vs +21.1% for the index.
Each line shows $100 invested at the moment EHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices EHC would reach each dislocation threshold.
Dislocation Price Levels
Prices where EHC's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $86.36 | Unusually cheap — potential buy zone |
| Value | +1σ | $91.89 | Cheap vs. own history |
| Fair Value | +0σ | $98.16 | Historical mean behavior |
| Expensive | -1σ | $105.36 | Expensive vs. own history |
| Deep Expensive | -2σ | $113.69 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from EHC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
EHC has crossed below its 200-week MA 24 times with an average 1-year return of +-0.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Oct 1987 | Dec 1987 | 8 | 15.7% | +3.6% | +1628.7% |
| Feb 1988 | Feb 1988 | 4 | 8.1% | +4.3% | +1461.4% |
| Apr 1988 | Jan 1989 | 42 | 25.9% | +1.1% | +1478.4% |
| Feb 1989 | Mar 1989 | 5 | 3.3% | +36.0% | +1531.6% |
| Feb 1993 | Nov 1993 | 41 | 35.8% | +62.9% | +591.5% |
| Sep 1998 | Sep 1998 | 1 | 0.4% | -69.7% | +61.3% |
| Sep 1998 | Jun 2001 | 143 | 73.7% | -38.7% | +212.3% |
| Oct 2001 | Nov 2001 | 4 | 11.4% | -63.1% | +141.8% |
| Jan 2002 | Mar 2002 | 7 | 13.3% | -66.2% | +151.7% |
| Jul 2002 | Aug 2002 | 4 | 31.5% | -84.7% | +208.7% |
| Aug 2002 | Mar 2006 | 184 | 99.2% | -39.7% | +464.4% |
| May 2006 | Aug 2006 | 13 | 17.0% | -13.5% | +586.0% |
| Nov 2006 | Nov 2006 | 1 | 3.1% | -5.0% | +620.3% |
| Jan 2007 | Jan 2007 | 1 | 1.3% | -18.1% | +597.1% |
| Mar 2007 | Nov 2009 | 141 | 63.2% | -21.9% | +561.4% |
| Feb 2010 | Mar 2010 | 4 | 3.6% | +30.5% | +783.6% |
| Aug 2010 | Aug 2010 | 3 | 2.0% | +11.9% | +776.9% |
| Sep 2011 | Oct 2011 | 5 | 17.5% | +59.7% | +885.4% |
| Nov 2011 | Jan 2012 | 9 | 9.2% | +23.2% | +800.4% |
| Feb 2016 | Feb 2016 | 2 | 3.8% | +33.2% | +361.5% |
| Mar 2020 | Mar 2020 | 1 | 8.2% | +62.2% | +162.1% |
| Oct 2021 | Mar 2022 | 22 | 13.7% | +9.9% | +102.8% |
| Apr 2022 | Oct 2022 | 27 | 17.3% | +21.3% | +90.9% |
| Mar 2023 | Apr 2023 | 4 | 5.0% | +44.6% | +88.3% |
| Average | 28 | — | +-0.7% | — |
Frequently Asked Questions
Is EHC below its 200-week moving average?
No. Encompass Health Corporation (EHC) is currently 15.2% above its 200-week moving average of $85.06. It would need to fall to $85.06 to cross below the line.
What is EHC's 200-week moving average price?
Encompass Health Corporation's 200-week moving average is $85.06 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when EHC drops below its 200-week moving average?
EHC has crossed below its 200-week moving average 24 times in our data. The average one-year return after these crossings was -0.7%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 28 weeks on average.
Is EHC a good value right now?
Here's what our data says about EHC as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 47. Free cash flow yield is 2.9%. Return on equity is 25.2%. Price-to-book is 3.9x. This is not a buy or sell recommendation — always do your own research.
How does EHC compare to the S&P 500?
Over the past 33.5 years, $100 invested in EHC would have grown to $594, compared to $3097 for the S&P 500. That's 5.5% annualized vs 10.8% for the index. EHC has underperformed the broader market over this period.
Does EHC pay a dividend?
Yes. Encompass Health Corporation currently pays a dividend yield of 76.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19